Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial

INTRODUCTION: The efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, was evaluated in patients with type 2 diabetes mellitus (T2DM) inadequately controlled on sulfonylurea monotherapy. METHODS: The CANagliflozin cardioVascular Assessment Study (CANVAS) is a do...

Descripción completa

Detalles Bibliográficos
Autores principales: Fulcher, Greg, Matthews, David R., Perkovic, Vlado, de Zeeuw, Dick, Mahaffey, Kenneth W., Weiss, Robert, Rosenstock, Julio, Capuano, George, Desai, Mehul, Shaw, Wayne, Vercruysse, Frank, Meininger, Gary, Neal, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575303/
https://www.ncbi.nlm.nih.gov/pubmed/26081793
http://dx.doi.org/10.1007/s13300-015-0117-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575303/
https://www.ncbi.nlm.nih.gov/pubmed/26081793
http://dx.doi.org/10.1007/s13300-015-0117-z

Ejemplares similares